Epygen Biotech | About the Biopharmaceutical company

Epygen Biotech is a Biopharmaceutical company, engaged in research and manufacturing of Therapeutic Proteins for Oncology, Cardiovascular, Immune disorders and Vaccines. The group’s decades long experience in expression of recombinant protein and innovations in protein separation is utilized in making affordable biologics for patients in the region.

Vision Statement

To emerge as a leading biotech innovator

enhancing human life

Mission Statement

Improve human life by Innovation in Biotechnology and exploration of new paths to a sustainablefuture

Ensure constant development of employees, customers and associates and walk the extra mile to achieve it

Develop and secure intellectual property of Therapeutic Proteins and make highest quality Biopharmaceuticals more affordable for patients

Nurture individual creativity and keep the pipeline full with products and solutions for tomorrow

Take long term perspective for balancing economic goals with socially responsible processes and operation

MANAGEMENT

Debayan Ghosh

Founder & CMD

Debayan’s vision for Epygen is to “emerge as a leading biotech innovator enhancing human life”. Having worked for leading Biotech companies in the United States and India for more than a decade prior to founding Epygen, Debayan realized the potential for biotechnology to shape tomorrow’s world, as in Epygen’s tag line “building future strand by strand”. Through his education and experience, he observed how modification of proteins using the recombinant path revolutionized areas from critical healthcare to chemicals and clean energy. Leading a team of scientists, technologists and business professionals at Epygen’s labs, manufacturing facilities and offices in Dubai, India and USA, innovation for sustainable development had been his key focus. Debayan obtained a Master of Technology degree from the Centre for Biotechnology – India, and has taken International business courses from the IIM. He has authored several scientific publications in international journals and patents.

INEEYAN ARIYARATNAM

FOUNDER & MD

Before joining Epygen, Ineeyan worked as a Director of Business development & Finance with Fabpro Specialities, a Multinational specialty chemical corporation, where he restructured international sourcing and fund disbursement, developing new and profitable business verticals. Ineeyan has a BSc Business Management degree from Kings College of London and an MBA in Operations and Finance from SP Jain Institute.

SOUMITRO DEB

RESIDENT DIRECTOR

A qualified engineer, Soumit’s focus area had been in advanced machines and instrumentation. After heading operations in a renowned precision machine designing and manufacturing company for nearly 2 decades, Soumit took up the task of setting up and running of Epygen’s state of the art Biopharmaceutical plant in India at its highest efficiency and complying to highest regulatory standards.

SUBIR CHANDRA

CHIEF FINANCIAL OFFICER

Mr. Chandra had been leading the financial operations of large corporates in India for over 4 decades and brings with him a plethora of expertise in cost and financial management like cost volume profit and overall cost reduction to achieve the company’s financial goals. He holds a Cost Accountancy degree from ICA India.

SCIENTIFIC TEAM

Saptarshi Paul

Lead Scientist

Dr. Paul is an established scientist in the field of, Molecular biology and Biotechnology. Prior to joining Epygen he worked at the prestigious Tata Institute of Fundamental Research and US Vitamins for 13 years at various research levels on biosimilars and therapeutic protein development. For nearly a decade prior to that, Dr. Paul did research at Thomas Jefferson University-Philadelphia and UMDNJ-RWJMS, Rutgers, New Jersey, USA. His areas of expertise include recombinant therapeutics, mammalian and yeast gene cloning and expression, vector design and engineering, protein purification, gene regulation and protein engineering. Dr. Paul is a Ph.D. in Biochemistry from Jadavpur University, India.

RISHIKESH GUPTA

Bioprocess - SENIOR manager

Dr. Gupta is involved in Epygen as a Bioprocess Scientist developing fermentation technology, protein purification and strain development at the Biotech Incubation Center. Dr. Gupta has obtained his M.Tech. in Biotechnology and Ph.D. in Industrial Biotechnology from Anna University, Chennai, India.

DINAKAR PANATI

HEAD – REGULATORY AFFAIRS

Dr. Dinakar Panati is involved in Epygen as a Head of Regulatory affairs. He comes from a background of working over a decade in the areas of Formulation; Regulatory Affairs as well as key product management. Dinakar holds a PhD from VIT University, Vellore, India.

PUNIT BANSAL

SENIOR SCIENTIST

Dr. Punit is a specialist in preclinical Drug Discovery of metabolic disorders (diabetes and obesity), pain and inflammation. He has worked extensively over 8 years in pharmacological profiling of new drug molecules and his industrial experience prior to Epygen group had been with Panacea Biotec Ltd, India. He has several publications to his credit and reviews international journals. Punit holds a Ph. D. in Pharmacology from Manipal College of Pharmaceutical Sciences, India.